We then validated the expression of each lncRNA in a group of mixed origin cancer cell lines (HepG2 hepatocellular carcinoma, A549 lung cancer and U2OS osteosarcoma; Figure S1A–C, Supporting Information) along with the previously characterized glucose‐responsive gene STC2. This evidence concerns the gene STC2 and hepatocellular carcinoma.